249 related articles for article (PubMed ID: 18267354)
1. Does minocycline have antidepressant effect?
Pae CU; Marks DM; Han C; Patkar AA
Biomed Pharmacother; 2008 Jun; 62(5):308-11. PubMed ID: 18267354
[TBL] [Abstract][Full Text] [Related]
2. Does neurotropin-3 have a therapeutic implication in major depression?
Pae CU; Marks DM; Han C; Patkar AA; Steffens D
Int J Neurosci; 2008 Nov; 118(11):1515-22. PubMed ID: 18853330
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant-like actions of minocycline combined with several glutamate antagonists.
Molina-Hernández M; Tellez-Alcántara NP; Pérez-García J; Olivera-Lopez JI; Jaramillo-Jaimes MT
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):380-6. PubMed ID: 17933448
[TBL] [Abstract][Full Text] [Related]
4. Glatiramer acetate could be a potential antidepressant through its neuroprotective and anti-inflammatory effects.
Tsai SJ
Med Hypotheses; 2007; 69(1):145-8. PubMed ID: 17196755
[TBL] [Abstract][Full Text] [Related]
5. Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats.
Molina-Hernández M; Téllez-Alcántara NP; Pérez-García J; Olivera-Lopez JI; Jaramillo-Jaimes MT
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1660-6. PubMed ID: 18640173
[TBL] [Abstract][Full Text] [Related]
6. Sipatrigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two-pore-domain K+ channel TREK-1.
Tsai SJ
Med Hypotheses; 2008; 70(3):548-50. PubMed ID: 17703894
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression.
Pae CU; Lee C; Paik IH
Med Hypotheses; 2007; 69(1):132-5. PubMed ID: 17196760
[TBL] [Abstract][Full Text] [Related]
8. sigma-1 receptors in major depression and anxiety.
Kulkarni SK; Dhir A
Expert Rev Neurother; 2009 Jul; 9(7):1021-34. PubMed ID: 19589051
[TBL] [Abstract][Full Text] [Related]
9. The role of CREB in depression and antidepressant treatment.
Blendy JA
Biol Psychiatry; 2006 Jun; 59(12):1144-50. PubMed ID: 16457782
[TBL] [Abstract][Full Text] [Related]
10. What should animal models of depression model?
Frazer A; Morilak DA
Neurosci Biobehav Rev; 2005; 29(4-5):515-23. PubMed ID: 15893377
[TBL] [Abstract][Full Text] [Related]
11. Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate?
Buller KM; Carty ML; Reinebrant HE; Wixey JA
J Neurosci Res; 2009 Feb; 87(3):599-608. PubMed ID: 18831005
[TBL] [Abstract][Full Text] [Related]
12. Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels.
Tsai SJ
Med Hypotheses; 2006; 67(5):1185-8. PubMed ID: 16797865
[TBL] [Abstract][Full Text] [Related]
13. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
14. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior.
Schmidt HD; Duman RS
Behav Pharmacol; 2007 Sep; 18(5-6):391-418. PubMed ID: 17762509
[TBL] [Abstract][Full Text] [Related]
15. Deltamethrin, a pyrethroid insecticide, could be a potential antidepressant agent.
Tsai SJ
Med Hypotheses; 2006; 66(3):605-8. PubMed ID: 16310970
[TBL] [Abstract][Full Text] [Related]
16. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
17. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
18. Assessing activity onset time and efficacy for clinically effective antidepressant and antimanic drugs in animal models based on dominant-submissive relationships.
Malatynska E; Pinhasov A; Creighton CJ; Crooke JJ; Reitz AB; Brenneman DE; Lubomirski MS
Neurosci Biobehav Rev; 2007; 31(6):904-19. PubMed ID: 17597209
[TBL] [Abstract][Full Text] [Related]
19. Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies.
Drzyzga ŁR; Marcinowska A; Obuchowicz E
Brain Res Bull; 2009 Jun; 79(5):248-57. PubMed ID: 19480984
[TBL] [Abstract][Full Text] [Related]
20. Rise and fall of minocycline in neuroprotection: need to promote publication of negative results.
Diguet E; Gross CE; Tison F; Bezard E
Exp Neurol; 2004 Sep; 189(1):1-4. PubMed ID: 15296829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
